Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **nematode nicotinic acetylcholine receptor like-23 (ACR-23)** is a homopentameric ligand-gated cation channel found in nematodes, most studied in *Caenorhabditis elegans*[1][5]. It belongs to the Cys-loop family of ligand-gated ion channels and is structurally homologous to mammalian α7 nicotinic acetylcholine receptors, although it is nematode-specific and has significant differences in ligand specificity[1][3]. ACR-23 functions primarily as a betaine-gated channel with key roles in maintaining normal locomotion in nematodes[3]. The anthelmintic drug monepantel, from the amino-acetonitrile derivative (AAD) class, exerts its effects by acting as a positive allosteric modulator of ACR-23, causing prolonged activation, hypercontraction of body wall muscles, and death of the worm[1][3][5]. Loss-of-function mutations in acr-23 confer resistance to monepantel, making it a major marker for drug efficacy and resistance surveillance[5]. ACR-23 is a validated therapeutic target for nematode control and is highly selective for nematode channels, minimizing safety concerns for use in agriculture and veterinary medicine[1][5].
Positive allosteric modulation (monepantel induces channel opening); Agonist activation (betaine acts as endogenous agonist; monepantel acts as modulator and indirect agonist); Overactivation leads to hypercontraction and nematode paralysis and death
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nematode nicotinic acetylcholine receptor like-23 (ACR-23).